• Nigericin Sodium Salt: Precision Ionophore for Translational

  2026-05-15

  This thought-leadership article explores how Nigericin sodium salt, a potassium ionophore from APExBIO, is transforming translational research. Blending mechanistic insights with actionable strategy, it bridges in vitro assay design, cytoplasmic pH regulation, and selective ion transport to emergent translational opportunities in cancer biology, toxicology, and platelet physiology. Evidence-based recommendations, protocol guidance, and a candid analysis of cross-domain maturity empower researchers to amplify the relevance and reproducibility of their experimental work.

• Berberine Hydrochloride: Advanced Workflows in Metabolic Dis

  2026-05-15

  Berberine hydrochloride stands out as a potent tool for translational research, uniquely bridging metabolic regulation and inflammasome modulation. This guide details workflow enhancements, troubleshooting strategies, and actionable protocol parameters for leveraging APExBIO's Berberine Hydrochloride in metabolic, cardiovascular, and acute inflammation models.

• Rotigotine Hydrochloride: Dopamine D2/D3 Agonist for Advance

  2026-05-14

  Rotigotine hydrochloride empowers researchers with high-affinity, stable dopaminergic activity for modeling Parkinson’s disease, restless legs syndrome, and related neurodegenerative conditions. This guide details optimized experimental workflows, cross-model applications, and practical troubleshooting strategies, translating clinical and preclinical advances into bench-ready protocols.

• Humanized Mice Reveal Species Differences in Prodrug Metabol

  2026-05-14

  This study demonstrates how humanized liver mice can resolve species-specific differences in the metabolism of ester prodrugs, using HD56 as a model compound. The findings establish a strong in vivo-in vitro correlation for prodrug activation in humanized mice, offering a more predictive platform for translational drug development.

• Prestained Protein Marker: Triple Color Ladder for SDS-PAGE

  2026-05-13

  The Prestained Protein Marker (Triple color, EDTA free, 10-250 kDa) redefines protein size verification and transfer monitoring for SDS-PAGE and Western blotting. Its tri-color, EDTA-free design uniquely enables advanced applications, including phosphoprotein and fluorescent analyses, while streamlining workflows in translational research.

• Clozapine in Schizophrenia Research: Protocols, Workflows, a

  2026-05-13

  Clozapine stands out as an atypical antipsychotic medication, enabling unique interrogation of ERK1/2 and EGF receptor signaling in preclinical schizophrenia research. This guide deciphers practical workflows, optimization strategies, and troubleshooting insights for effective Clozapine use in cell and animal models.

• TaqI Restriction Endonuclease: Fast, Reliable DNA Digestion

  2026-05-12

  TaqI Restriction Endonuclease (SKU K3053) enables rapid, sequence-specific digestion of plasmid, PCR, or genomic DNA, optimizing workflows that require fast and efficient DNA cleavage. It is best suited for molecular biology research applications where time efficiency and sticky end generation are critical. This product is not intended for diagnostic or medical use.

• Entecavir (BMS200475): Precision Inhibition of HBV Replicati

  2026-05-12

  Entecavir (BMS200475) sets the benchmark for potent, selective chronic hepatitis B virus replication inhibition, even in lamivudine-resistant and decompensated liver disease scenarios. This article delivers evidence-based workflow enhancements, protocol parameters, and troubleshooting insights for maximizing research impact with Entecavir from APExBIO.

• Olsalazine Sodium in Cancer Research: Workflows, Use-Cases,

  2026-05-11

  Olsalazine Sodium empowers cancer and inflammation researchers with a potent, water-soluble mesalamine dimer for robust inhibition of LTB4-mediated chemotaxis. This guide distills reference-backed protocols and novel applications—spanning tumor models to xenobiotic transport studies—while providing actionable troubleshooting insights for reproducible results.

• miR-3180 Suppresses HCC Metastasis by Targeting Lipid Metabo

  2026-05-11

  Hong et al. (2023) delineate the role of miR-3180 as a dual regulator of lipid synthesis and uptake in hepatocellular carcinoma (HCC). By directly repressing SCD1 and CD36, miR-3180 impedes tumor growth and metastasis, suggesting its potential as both a therapeutic target and prognostic indicator in HCC.

• Olsalazine Sodium: Protocols & Troubleshooting in Cancer Res

  2026-05-10

  Olsalazine Sodium, a potent mesalamine dimer, is advancing inflammation and cancer biology research with unique workflow advantages. Explore experimental protocols, troubleshooting strategies, and actionable insights for robust, reproducible results in colorectal cancer and xenobiotic transport models.

• 2-Deoxy-D-glucose: Precision Immunometabolic Modulation in R

  2026-05-09

  Explore how 2-Deoxy-D-glucose (2-DG) precisely modulates immune cell metabolism, offering unique insights for cancer and autoimmune research. This article reveals new assay strategies and translational implications beyond standard glycolysis inhibition.

• Anemoside B4 Blocks NLRP3 Inflammasome in Macrophages to All

  2026-05-09

  This study uncovers that Anemoside B4 (AB4) alleviates DSS-induced colitis in mice by selectively inhibiting CD1d-dependent NLRP3 inflammasome activation in colonic macrophages. The findings reveal a novel anti-inflammatory mechanism involving the suppression of AKT-STAT1-PRDX1-NF-κB signaling, highlighting AB4’s potential as a targeted therapeutic for ulcerative colitis.

• Anti-ROR1 Antibody (Zilovertamab): Precision Oncology and Li

  2026-05-08

  Explore how Anti-ROR1 Antibody (Zilovertamab) advances cancer research and bridges mechanistic insights from liver injury models. Discover new assay strategies grounded in the latest findings on mitophagy, Wnt5a-induced ROR1 signaling inhibition, and practical protocol decisions.

• Imidazoline Blockade of β-Cell K+ Channels Elevates Insulin

  2026-05-07

  This study demonstrates that imidazoline antagonists of α2-adrenoceptors increase insulin secretion in vitro by directly inhibiting ATP-sensitive K+ channels in pancreatic β-cells, rather than through classic receptor blockade. The findings clarify the mechanism behind the insulinotropic effects of these compounds and inform new strategies for metabolic research and drug development.

450 records 18/30 page Previous Next First page 上5页 1617181920 下5页 Last page